FeesSafety
Pluang+

Bitcoin dips below $75K amid $201M ETF outflows on Nov. 9, signaling cautious investor sentiment.

Market News
10 Nov 2026, 13:59 WIB
Tokenpost
View Source
Bearish
Bitcoin dips below $75K amid $201M ETF outflows on Nov. 9, signaling cautious investor sentiment.

Bitcoin traded at $74,362 on Nov. 9, falling below its previous daily close of $75,267. On the same day, U.S. spot Bitcoin ETFs saw net outflows totaling $201 million, with the iShares Bitcoin Trust experiencing $213.2 million in withdrawals. Although MSBT had $22.1 million in inflows, it only partially offset the outflows. From Nov. 2 to Nov. 9, these funds recorded a net outflow of $1.4827 billion, reflecting a cautious stance among investors. These ETF flows highlight some institutional selling pressure but do not fully explain Bitcoin’s price movements.

Bitcoin's trading at $74,362 and U.S. spot ETF outflows totaling $201 million provide context for cryptocurrency market activity. For readers following digital assets, here is Pluang's market snapshot as of Nov 10, 2026 18:41 WIB: Among 50 major cryptocurrencies, 31 rose and 18 fell today. Basic Attention Token (BAT) gained 4.18% to Rp2.338 with 99% buy orders, while Cosmos (ATOM) rose 3.85% to Rp25.108 with a 62% buy ratio, and The Sandbox (SAND) increased 3.78% to Rp782 with 80% buy activity.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
22 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
22 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
22 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
22 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App